Form 4: BNY Mellon Director Receives Deferred Stock Units

Director Marguerite Amy Gilliland was granted 1,592 deferred stock units as part of BNY Mellon's compensation structure.

Summary

• Director Marguerite Amy Gilliland acquired 1,592 deferred stock units on April 17, 2026.
• The units are granted on a 1-for-1 basis relative to common stock.
• Following this transaction, the director holds a total of 21,726.015 deferred stock units.
• The units vest on the earlier of the 2027 Annual Meeting or one year from the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Value of deferred stock units is subject to market fluctuations in BNY Mellon common stock price.

Future Outlook

The deferred stock units will vest on the earlier of the 2027 Annual Meeting of Shareholders or one year from the grant date, with payout occurring upon termination of service as a director.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the financial services sector to ensure alignment with shareholder interests.

Comparison to Industry Standards

• The grant of deferred stock units is consistent with standard director compensation packages at large-cap financial institutions like JPMorgan Chase, State Street, and Citigroup.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation disclosure.

Next Steps

• Vesting of units at the 2027 Annual Meeting or one year from grant date.

Key Dates

Keywords

BNY Mellon, BK, Director Compensation, Form 4, Insider Trading, Equity Grant